[Inhalation therapy: provocation tests, infectious risks, acute bronchiolitis and ENT diseases. GAT aerosolstorming, Paris 2011]

M Dres; A Ferre; M-H Becquemin; J-F Dessanges; G Reychler; M Durand; V Escabasse; E Sauvaget; J-C Dubus

doi:10.1016/j.rmr.2011.11.018

[Inhalation therapy: provocation tests, infectious risks, acute bronchiolitis and ENT diseases. GAT aerosolstorming, Paris 2011]

Rev Mal Respir. 2012 Dec;29(10):1186-97. doi: 10.1016/j.rmr.2011.11.018. Epub 2012 Nov 12.

[Article in French]

Authors

M Dres¹, A Ferre, M-H Becquemin, J-F Dessanges, G Reychler, M Durand, V Escabasse, E Sauvaget, J-C Dubus

Affiliation

¹ Service de Pneumologie et Réanimation, Hôtel-Dieu, Université Paris Descartes, 75004 Paris, France.

PMID: 23228677
DOI: 10.1016/j.rmr.2011.11.018

Abstract

Communications from the 2011 meeting of the GAT are reported in this second article on the practical management of bronchial provocation tests and infectious risks associated with the use of nebulization. Recent advances on the role of nebulized hypertonic saline in the treatment of acute bronchiolitis in infants and of the nebulization in sinusal diseases are also reported.

Publication types

English Abstract
Review

MeSH terms

Acute Disease
Administration, Inhalation
Bronchial Provocation Tests* / adverse effects
Bronchial Provocation Tests* / methods
Bronchial Provocation Tests* / trends
Bronchiolitis* / epidemiology
Bronchiolitis* / etiology
Bronchiolitis* / therapy
Congresses as Topic*
Humans
Nebulizers and Vaporizers
Otorhinolaryngologic Diseases* / etiology
Otorhinolaryngologic Diseases* / therapy
Paris
Respiratory Therapy / adverse effects
Respiratory Therapy / methods*
Respiratory Therapy / trends
Respiratory Tract Infections / epidemiology
Respiratory Tract Infections / etiology*
Risk Factors
Societies, Medical / organization & administration